|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 55.29 INR | -2.30% |
|
-3.03% | +34.21% |
| Market Cap | 18.52B 193M 170M 158M 145M 273M 276M 1.88B 734M 9.15B 725M 709M 31.61B | P/E 2024 |
22.4x | P/E 2025 | 21.8x |
|---|---|---|---|---|---|
| Enterprise Value | 18.52B 193M 170M 158M 145M 273M 276M 1.88B 734M 9.14B 725M 709M 31.61B | EV / Sales 2024 |
1.27x | EV / Sales 2025 | 1.45x |
| Free-Float |
56.3% | Yield 2024 * |
-
| Yield 2025 | 0.42% |
| 1 day | -2.60% | ||
| 1 week | -3.03% | ||
| Current month | -6.81% | ||
| 1 month | +0.92% | ||
| 3 months | +30.37% | ||
| 6 months | +54.48% | ||
| Current year | +34.21% |
| 1 week | 51.43 |  | 56.98 |
| 1 month | 51.43 | | 64.57 |
| Current year | 33.44 | | 64.57 |
| 1 year | 33.44 | | 64.57 |
| 3 years | 29.51 | | 100.8 |
| 5 years | 23.65 | | 100.8 |
| 10 years | 7.21 | | 100.8 |
| Manager | Title | Age | Since |
|---|---|---|---|
Sanjay Suri
CEO | Chief Executive Officer | 57 | 01/07/2026 |
Sushil Suri
CEO | Chief Executive Officer | 62 | 01/02/1992 |
| Director of Finance/CFO | 59 | 03/04/2002 |
| Director | Title | Age | Since |
|---|---|---|---|
Sushil Suri
CHM | Chairman | 62 | 01/02/1992 |
| Director/Board Member | 57 | 13/08/2019 | |
Savita
BRD | Director/Board Member | - | 22/06/2020 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -2.30% | -3.03% | -4.21% | +79.43% | 323M | |
| +0.13% | +4.41% | +47.35% | +163.20% | 1,068B | |
| +0.97% | +6.88% | +58.02% | +53.12% | 641B | |
| -0.94% | +1.39% | +35.02% | +72.60% | 454B | |
| +0.49% | +8.21% | +38.60% | +34.08% | 351B | |
| +0.49% | +2.74% | +38.18% | +42.91% | 299B | |
| -1.02% | +2.11% | +18.22% | +15.36% | 266B | |
| +0.39% | +1.28% | -27.25% | -37.89% | 220B | |
| +0.06% | +3.32% | +22.73% | +59.40% | 203B | |
| +0.94% | -2.02% | +12.32% | +70.59% | 162B | |
| Average | +0.28% | +2.20% | +23.90% | +55.28% | 366.37B | |
| Weighted average by Cap. | +0.89% | +2.85% | +36.60% | +77.88% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 17.02B 177M 156M 145M 133M 250M 254M 1.73B 674M 8.4B 666M 652M 29.05B | 18.12B 189M 166M 155M 142M 267M 270M 1.84B 718M 8.95B 709M 694M 30.92B |
| Net income | 962M 10.03M 8.81M 8.21M 7.54M 14.15M 14.34M 97.53M 38.09M 475M 37.64M 36.83M 1.64B | 1.18B 12.31M 10.82M 10.07M 9.25M 17.37M 17.6M 120M 46.75M 583M 46.2M 45.2M 2.01B |
| Net Debt | 121M 1.26M 1.1M 1.03M 945K 1.77M 1.8M 12.23M 4.78M 59.52M 4.72M 4.62M 206M | -928K -9.68K -8.51K -7.92K -7.27K -13.66K -13.84K -94.13K -36.76K -458K -36.33K -35.54K -1.58M |
Employees
1,814
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 28/07/26 | ₹55.29 | -2.30% | 216,758 |
| 27/07/26 | ₹56.59 | +5.21% | 503,493 |
| 24/07/26 | ₹53.79 | +2.57% | 427,315 |
| 23/07/26 | ₹52.44 | -1.56% | 383,575 |
| 22/07/26 | ₹53.27 | -6.28% | 676,524 |
- Stock Market
- Stocks
- MOREPENLAB Stock
Select your edition
All financial news and data tailored to specific country editions
